Vincristine Market Growth Outlook with Pfizer & Cipla
Vincristine Market Growth Outlook with Pfizer and Cipla1 The Vincristine Market is poised for steady expansion over the forecast period, driven by rising cancer prevalence, improved access to chemotherapy drugs, and increasing focus on pediatric oncology. According to industry estimates, the market is anticipated to grow at a CAGR of 7.5% from 2026 to 2034, reflecting stable...
0 Yorumlar 0 hisse senetleri 87 Views 0 önizleme